Consistent performance with control where it matters
FRS (Foetal Bovine Serum Replacement Solution) is a chemically defined, animal-free serum replacement designed to support routine cell culture in standard basal media. It delivers reliable, batch-to-batch consistent performance across a broad range of standard cell lines, removing the need for serum batch-testing or stockpiling. FRS supports both suspension and adherent systems, with cell attachment handled separately on a cell-type specific basis. Its defined composition allows researchers to control the presence or absence of biological inputs, such as cytokines or hormones, rather than inheriting undefined serum-derived background.
FRS can replace up to 90% of serum in more nutritionally demanding primary or organoid cell culture systems. Fully serum-free workflows for primary cell culture systems have been developed by pairing FRS with supplemented growth factors. FRS may also be combined with DMSO for use as a freeze medium in routine cryopreservation workflows.
FRS can replace up to 90% of serum in more nutritionally demanding primary or organoid cell culture systems. Fully serum-free workflows for primary cell culture systems have been developed by pairing FRS with supplemented growth factors. FRS may also be combined with DMSO for use as a freeze medium in routine cryopreservation workflows.
Why scientists switch to FRS?As a fully chemically defined supplement, scientists switch to FRS to eliminate serum variability. This prevents the need for batch testing and reduces background across workflows.
As a fully animal-origin-free supplement, FRS is also ideal for regulatory compliance. |
What FRS is not:FRS is not a cell-type–specific optimised medium or a perfect one-to-one substitute for fetal bovine serum for every application. Specifically, long-term culture of primary cells typically requires either retention of 1% FBS, or inclusion of cell-specific factors in the media (see application notes).
|
FRS Pioneer vs Fetal Bovine Serum: What you control
With FRS Pioneer:
FRS Pioneer shifts cell culture media from a black box to a controlled input. You trade hidden complexity for explicit, engineerable, and reproducible choice.
- Composition: Fully chemically defined. Every component is known.
- Growth factor & hormone exposure: Fixed, reproducible levels by design.
- Batch-to-batch variability: Minimal.
- Experimental reproducibility: High.
- Regulatory risk: Reduced. No animal-derived inputs.
- Supply risk: Low. Not tied to agricultural supply chains.
- Freeze media use: Compatible with DMSO as a defined freeze medium.
- Adhesion strategy: Explicit and modular. You choose the coating or surface based on your cell type.
- Minimal extracellular vesicles: For cleaner exosome studies or manufacturing.
- Composition: Undefined and complex. Thousands of components, largely uncharacterised.
- Growth factor & hormone exposure: Unknown and variable.
- Batch-to-batch variability: High. Requires lot testing and stockpiling.
- Experimental reproducibility: Lower. Media composition varies between lots.
- Regulatory risk: Higher. Animal-derived, with traceability and contamination concerns.
- Supply risk: High. Subject to seasonal, geographic, and ethical constraints.
- Freeze media use: Common but undefined.
- Adhesion strategy: Implicit. Serum masks attachment variability rather than controlling it.
- High background, bovine extracellular vesicles: Depletion typically necessary for exosome studies or manufacturing.
FRS Pioneer shifts cell culture media from a black box to a controlled input. You trade hidden complexity for explicit, engineerable, and reproducible choice.